Australia · Delayed Price · Currency is AUD Nexalis Therapeutics Statistics
Total Valuation
ASX:NX1 has a market cap or net worth of AUD 6.33 million. The enterprise value is 6.63 million.
| Market Cap | 6.33M |
| Enterprise Value | 6.63M |
Important Dates
The last earnings date was Friday, February 27, 2026.
| Earnings Date | Feb 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ASX:NX1 has 253.04 million shares outstanding. The number of shares has increased by 1.06% in one year.
| Current Share Class | 253.04M |
| Shares Outstanding | 253.04M |
| Shares Change (YoY) | +1.06% |
| Shares Change (QoQ) | -9.99% |
| Owned by Insiders (%) | 26.32% |
| Owned by Institutions (%) | 4.23% |
| Float | 108.60M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 8.24 |
| PB Ratio | -5.38 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -3.62 |
| EV / Sales | 8.64 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.58
| Current Ratio | 0.58 |
| Quick Ratio | 0.55 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -12.40 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -110.17% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 197.18% |
| Weighted Average Cost of Capital (WACC) | 3.89% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.80 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +8.70% in the last 52 weeks. The beta is -0.29, so ASX:NX1's price volatility has been lower than the market average.
| Beta (5Y) | -0.29 |
| 52-Week Price Change | +8.70% |
| 50-Day Moving Average | 0.03 |
| 200-Day Moving Average | 0.03 |
| Relative Strength Index (RSI) | 50.08 |
| Average Volume (20 Days) | 302,236 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ASX:NX1 had revenue of AUD 767,691 and -1.83 million in losses. Loss per share was -0.01.
| Revenue | 767,691 |
| Gross Profit | 767,691 |
| Operating Income | -1.69M |
| Pretax Income | -1.83M |
| Net Income | -1.83M |
| EBITDA | n/a |
| EBIT | -1.69M |
| Loss Per Share | -0.01 |
Balance Sheet
The company has 436,900 in cash and 741,278 in debt, with a net cash position of -304,378 or -0.00 per share.
| Cash & Cash Equivalents | 436,900 |
| Total Debt | 741,278 |
| Net Cash | -304,378 |
| Net Cash Per Share | -0.00 |
| Equity (Book Value) | -1.18M |
| Book Value Per Share | -0.01 |
| Working Capital | -858,508 |
Cash Flow
| Operating Cash Flow | -888,173 |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 100.00%, with operating and profit margins of -220.50% and -238.28%.
| Gross Margin | 100.00% |
| Operating Margin | -220.50% |
| Pretax Margin | -238.28% |
| Profit Margin | -238.28% |
| EBITDA Margin | n/a |
| EBIT Margin | -220.50% |
| FCF Margin | n/a |
Dividends & Yields
ASX:NX1 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.06% |
| Shareholder Yield | -1.06% |
| Earnings Yield | -28.92% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |